期刊文献+

慢性肾病成纤维细胞生长因子-23与左心室肥大关系研究 被引量:6

原文传递
导出
摘要 目的:探讨透析前慢性肾病患者成纤维细胞生长因子-23(fibroblast growth factor-23,FGF-23)与左心室肥大的关系。方法:159例慢性肾病患者和63例非慢性肾病患者,分析主要临床资料及实验室检查结果,经彩超检查其左心室质量指数,并对相关资料进行单变量、多变量回归分析及方差分析。结果:与非慢性肾病患者相比,慢性肾病患者左心室质量指数明显增加,左心室肥大发生率高,且射血分数明显下降;平均血磷浓度和LogFGF-23增加值均与肾小球滤过率水平下降呈明显相关(P均<0.01);不同肾功能组别患者平均血磷浓度均正常,但LogFGF-23绝对值随患者肾功能减退明显增加;单变量回归分析显示,慢性肾病患者增加的LogFGF-23与增加的左心室质量指数密切相关,且与左心室肥大存在独立相关性。结论:慢性肾病患者中FGF-23与左心室质量指数和左心室肥大存在独立相关性。
出处 《中华实用诊断与治疗杂志》 2011年第6期616-618,共3页 Journal of Chinese Practical Diagnosis and Therapy
  • 相关文献

参考文献10

  • 1Coresh J, Selvin E, Stevens l.. A, et al. Prevalence of chronic kidney disease in the United States[J]. JAMA,2007,298(17):2038-2047.
  • 2Mirza M A, Larsson A, Melhus H, et al. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population[J]. Atherosclerosis, 2009,207 (2) : 546- 551.
  • 3Block G A, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate hinder choice in incident hemodialysis patients[J]. Kidney Int,2007,71(5):438-441.
  • 4Liu S, Quarles L D. How fibroblast growth factor 23 works[J].J Am Soc Nephrol,2007,18(6) :1637-1647.
  • 5Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia hut accentuates calcitriol deficiency in chronic kidney disease[J]. J Am Soe Nephrol,2005, 16(7) :2205-2215.
  • 6Mathew S, Tustison K S, Sugatani T, et al. The mechanism of phosphorus as a cardiovascular risk factor in CKD[J].J Am Soc Nephrol, 2008,19(6) : 1092- 1105.
  • 7Hughes S E. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues[J]. J Histochem Cytochem, 1997,45(7) :1005-1019.
  • 8Virag J A, Rolle M I., Reece J, et al. Fibroblast growth factor- 2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function[J]. Am J Pathol, 2007,171(5):1431- 1440.
  • 9Yu X, Ibrahimi O A, Goetz R, etal. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor 23[J].Endocrinology, 2005,146(11) : 4647-4656.
  • 10Gutierrez O M, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis[J]. N Engl J Med,2008,359(6):584- 592.

同被引文献74

  • 1Sbobeiri N, Adams MA, Holden RM. Phosphate: an old bone molecule but new cardiovascular risk factor[J]. Br J Clin Pharmacol, 2014,77 ( 1 ) : 39-54.
  • 2Marks J, Debnam ES, Unwin RJ. The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease[J]. Curr Opin Nephrol Hypertens,2013, 22(4) : 481-487.
  • 3Waheed AA, Pedraza F, Lenz O, et al. Phosphate control in end-stage renal disease: barriers and opportunities[J]. Nephrol Dial Transplant,2013,28(12) :2961-2968.
  • 4Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis [J]. JAMA,2011,305(11): 1119-1127.
  • 5Bellasi A, Mandreoli M, Baldrati L, et al. Chronic kidney disease progression and outcome according to serum phosphorus in mild to-moderate kidney dysfunction [J]. Clin J Am Soc Nephrol, 2011,6(4) :883-891.
  • 6Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population[J]. Nephrol Dial Transplant, 2011, 26 (6): 1948- 1955.
  • 7Voormolen N, Noordzij M, Grootendorst DC, et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients[J]. Nephrol Dial Transplant, 2007,22(10) :2909-2916.
  • 8Chue CD, Edwards NC, Davis LJ, et al. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease[J]. Nephrol Dial Transplant, 2011,26 (8): 2576-2582.
  • 9Sekiguchi S, Suzuki A, Asano S, et al. Phosphate overload induces podocyte injury via type III Na-dependent phosphate transporter[J]. Am J Physiol Renal Physiol, 2011,300 (4) :F848-856.
  • 10Shroff R. Phosphate is a vascular toxin[J]. Pediatr Nephrol, 2013,28(4) :583-593.

引证文献6

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部